Revvity's EUROIMMUN Launches Solution for Specific Typing of Alzheimer's Disease Associated APOE GeneBusiness Wire • 10/02/24
Revvity Signals Software's New Synergy Solution Redefines Collaboration Between Pharma and Contract PartnersBusiness Wire • 04/15/24